MARKET

PHAR

PHAR

Pharming Group N.V.
NASDAQ
16.19
-0.18
-1.10%
Closed 17:23 02/10 EST
OPEN
16.46
PREV CLOSE
16.37
HIGH
16.48
LOW
16.09
VOLUME
21.28K
TURNOVER
0
52 WEEK HIGH
21.34
52 WEEK LOW
7.50
MARKET CAP
1.11B
P/E (TTM)
397.79
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PHAR last week (0202-0206)?
Weekly Report · 1d ago
Pharming Group: Crossing From Speculation To Profitability
Seeking Alpha · 02/04 05:55
Pharming Group Sets 2026 Guidance and Showcases Rare Disease Pipeline at Investor Day
TipRanks · 02/03 11:57
Pharming Projects 2026 Revenue Of $405M To $425M, Driven By Joenja And RUCONEST Growth, With Operating Expenses Between $330M And $335M
Benzinga · 02/03 06:37
Pharming Group gibt Umsatzprognose von 405 bis 425 Millionen US-Dollar für 2026 bekannt
Reuters · 02/03 06:00
Pharming Group NV Forecasts 2026 Revenue of $405–$425 Million
Reuters · 02/03 06:00
PHARMING GROUP NV - 2026 OPERATING EXPENSE GUIDANCE OF $330-$335 MLN
Reuters · 02/03 06:00
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 02/02 17:05
More
About PHAR
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Webull offers Pharming Group NV stock information, including NASDAQ: PHAR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHAR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHAR stock methods without spending real money on the virtual paper trading platform.